4/18/2012

House Energy and Commerce Committee Republicans' five-year draft reauthorization of the Prescription Drug User Fee Act combines four user fee programs into one measure, creates programs for generic drugs and biosimilars, and encourages development of pediatric drugs.

Related Summaries